Table 1.
Clinical characteristics of the 204 patients.
| N | % | |
|---|---|---|
| Gender | ||
| Women | 80 | 39.2 |
| Men | 124 | 60.8 |
| Age at seizure onset (years) | ||
| ≤16 | 115 | 56.4 |
| >16 | 89 | 43.6 |
| Number of seizures before treatment | ||
| 1–9 times | 166 | 81.4 |
| ≥10 times | 38 | 18.6 |
| Pretreatment duration (months) | ||
| <6 | 97 | 47.5 |
| ≥6 | 107 | 52.5 |
| Seizure type | ||
| Partial | 157 | 77.0 |
| Generalized | 47 | 23.0 |
| Epilepsy etiology | ||
| Idiopathic | 74 | 36.3 |
| Symptomatic | 130 | 63.7 |
| MRI or CT record at entry | ||
| Normal | 132 | 64.7 |
| Abnormal | 72 | 35.3 |
| EEG at entry | ||
| Normal | 39 | 19.1 |
| Abnormal | 165 | 80.9 |
| Family history | ||
| No | 195 | 95.6 |
| Yes | 9 | 4.4 |
| History of febrile seizure | ||
| No | 188 | 92.2 |
| Yes | 16 | 7.8 |
6MSF, patients who were seizure-free over the initial 6 months; 6MNSF, patients who were not seizure-free over the initial 6 months; EEG, electroencephalography; MRI, magnetic resonance imaging; CT, computed tomography.